Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 500-092-7 | CAS number: 36890-68-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 24/09/1991- 8/10/1991
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 992
- Report date:
- 1992
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Version / remarks:
- 1987
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- ε-Caprolactone, oligomeric reaction products with 2,2'-oxydiethanol
- EC Number:
- 500-092-7
- EC Name:
- ε-Caprolactone, oligomeric reaction products with 2,2'-oxydiethanol
- Cas Number:
- 36890-68-3
- Molecular formula:
- C6H10O2x.C4H8O3
- IUPAC Name:
- 2-oxepanone, polymer with 2,2'-oxybis[ethanol]
- Reference substance name:
- Glycerol
- EC Number:
- 200-289-5
- EC Name:
- Glycerol
- Cas Number:
- 56-81-5
- Molecular formula:
- C3H8O3
- IUPAC Name:
- glycerol
- Test material form:
- liquid
Constituent 1
additive 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- The test animals were obtained from Harlan/CPB, Zeist, Netherlands. Male rats weighed 175-200g and females weighed 150-175g at study initiation. The rats were housed in Macrolon cages with 2-3 animals per cage. Rats had free access to food except for a period of about 18 hours prior to dosing and 6 hours after dosing. Water was available ad libitum.
Environmental conditions included; Temperature: 21-22 °C, Humidity: 50-70%, Air changes: approximately 16 per hr, Photoperiod: artificial light from 7am till 7 pm and Radio-sound: 24 hours per day. At the end of the study, all rats were killed by ether inhalation
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: tragacanth
- Details on oral exposure:
- CAPA 304 was suspended in a 1.25% tragacanth solution in distilled water. The final concentration was 0.2 g/ml.
- Doses:
- Single dose of 2000 mg/kg
- No. of animals per sex per dose:
- 5 animals/sex/ dose
- Control animals:
- no
- Details on study design:
- The duration of observation period following administration was 14 days. Rats were observed from 0-0.5 and at 1.5, 3 and 6 hours after application and thereafter on each day till the end of the experiment. Rats were weighed one day before dosing (day-1), at the day of dosing prior to dose administration (day 0) and at 2, 7 and 14 days after treatment. At the end of the study, all rats were killed by ether inhalation and an autopsy was performed which included the inspection of the external appearance, the cervical area, and the thoracic and abdominal cavities.
- Statistics:
- None required
Results and discussion
- Preliminary study:
- None performed
Effect levels
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortalities for the duration of the study
- Clinical signs:
- other: A slightly hunched posture and gait was observed in 4 out of 5 males and in all females between 30 and 90 minutes. No clinical signs were noticed 6 hours after dosing
- Gross pathology:
- With one exception of lungs with the appearance of emphysema observed in one female rat, no gross abnormalities were noted for any of the animals when necropsied at the conclusion of the 14-day observation period.
Any other information on results incl. tables
Table 1: Individual and mean body weights (g) of male and female rats given a single oral dose of CAPA 304
Sex |
Dose (mg/kg) |
Animal number |
Day -1 |
Day 0 |
Day 2 |
Day 7 |
Day 14 |
Male |
2000 |
1 |
199 |
184 |
206 |
228 |
254 |
2 |
199 |
184 |
206 |
210 |
223 |
||
3 |
197 |
186 |
217 |
242 |
280 |
||
4 |
189 |
185 |
207 |
196 |
219 |
||
5 |
187 |
187 |
215 |
235 |
268 |
||
Mean |
196.2 |
185.2 |
210.2 |
222.2 |
248.8 |
||
Female |
2000 |
1 |
165 |
155 |
169 |
161 |
172 |
2 |
151 |
143 |
156 |
151 |
161 |
||
3 |
171 |
158 |
173 |
179 |
188 |
||
4 |
157 |
146 |
159 |
154 |
161 |
||
5 |
165 |
151 |
169 |
179 |
191 |
||
Mean |
161.8 |
150.6 |
165.2 |
164.8 |
174.6 |
Table 2 : Mean body weight gain (g) of groups of five male and female rats given a single oral dose of CAPA 304
Sex |
Dose (mg/kg) |
Day -1 to 2 |
Day 2 to 7 |
Day 7 to 14 |
Day -1 to 14 |
Male |
2000 |
14.0 |
12.0 |
26.6 |
52.6 |
Female |
2000 |
3.4 |
-0.4 |
9.8 |
12.8 |
Applicant's summary and conclusion
- Interpretation of results:
- Category 5 based on GHS criteria
- Conclusions:
- Under the conditions of this study, CAPA 304 was of low toxicity to rats. The LD50 values for male and female animals was greater than 2000 mg/kg/bw
- Executive summary:
In this study ( method according to EEC – Directive 84-449, Annex V, Part B1 ) groups of 5 male and 5 female Wistar rats were given a single dose of CAPA 304 suspended in a 1.25% tragacanth solution in distilled water via a stomach tube (oral gavage). Animals were observed for 14 days following dosing, and all animal were examined macroscopically. Body weights were recorded one day before dosing (Day-1), at the day of dosing prior to dose administration (Day 0) and at 2, 7 and 14 days after treatment. No deaths were recorded for the duration of the study. Fasting on the day prior to dosing caused a small weight loss in all animals and there was a slight decrease in mean body weight gain between day 2 and 7 in female rats. With one exception of lungs with the appearance of emphysema observed in one female rat, no gross abnormalities were noted for any of the animals when necropsied. Clinical signs noticed only at the beginning of the study were; a slightly hunched posture and gait. The LD50 value for male and female animals was greater than 2000 mg/kg bw. Under the conditions of the study, CAPA 304 was of low toxicity in rats therefore classification according to Regulation (EC) No 1272/2008 is not required.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.